cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
Company profile
Ticker
CPIX
Exchange
Website
CEO
A. J. Kazimi
Employees
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
CPIX stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
9 Aug 24
8-K
Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth
6 Aug 24
10-Q
2024 Q1
Quarterly report
10 May 24
8-K
Cumberland Pharmaceuticals Reports First Quarter 2024
7 May 24
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 24
ARS
2023 FY
Annual report to shareholders
22 Mar 24
8-K
Other Events
20 Mar 24
424B5
Prospectus supplement for primary offering
20 Mar 24
DEFA14A
Additional proxy soliciting materials
13 Mar 24
DEF 14A
Definitive proxy
13 Mar 24
Transcripts
CPIX
Earnings call transcript
2024 Q2
6 Aug 24
CPIX
Earnings call transcript
2024 Q1
7 May 24
CPIX
Earnings call transcript
2023 Q3
7 Nov 23
CPIX
Earnings call transcript
2023 Q2
8 Aug 23
CPIX
Earnings call transcript
2023 Q2
8 Aug 23
CPIX
Earnings call transcript
2023 Q1
9 May 23
CPIX
Earnings call transcript
2022 Q4
7 Mar 23
CPIX
Earnings call transcript
2022 Q3
13 Nov 22
CPIX
Earnings call transcript
2022 Q2
13 Aug 22
CPIX
Earnings call transcript
2022 Q1
14 May 22
Financial summary
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 17.34 mm | 17.34 mm | 17.34 mm | 17.34 mm | 17.34 mm | 17.34 mm |
Cash burn (monthly) | 404.01 k | 76.05 k | 363.73 k | 927.15 k | 285.22 k | 59.64 k |
Cash used (since last report) | 1.18 mm | 222.45 k | 1.06 mm | 2.71 mm | 834.25 k | 174.43 k |
Cash remaining | 16.15 mm | 17.11 mm | 16.27 mm | 14.62 mm | 16.50 mm | 17.16 mm |
Runway (months of cash) | 40.0 | 225.0 | 44.7 | 15.8 | 57.9 | 287.8 |
Institutional ownership, Q1 2024
0.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 3 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 131.58 mm |
Total shares | 78.32 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
BK The Bank of New York Mellon Corporation | 75.27 k | $126.45 mm |
OAKC Oakworth Capital | 3.05 k | $5.13 mm |
Huntington National Bank | 1.00 | $2.00 k |
Proequities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Aug 24 | Kazimi A J | Common Stock | Acquire L | No | Yes | 1.35 | 27 | 36.45 | 5,697,703 | |
30 Aug 24 | Jones James | Common Stock | Acquire L | No | Yes | 1.35 | 27 | 36.45 | 35,553 | |
30 Aug 24 | Krogulski Kenneth | Common Stock | Acquire L | No | Yes | 1.35 | 133 | 179.55 | 252,027 | |
30 Aug 24 | Young Caroline | Common Stock | Acquire L | No | Yes | 1.35 | 13 | 17.55 | 27,858 | |
30 Aug 24 | Young Caroline | Common Stock | Acquire L | No | Yes | 1.35 | 13 | 17.55 | 27,858 | |
29 Aug 24 | Kazimi A J | Common Stock | Acquire L | No | Yes | 1.41 | 50 | 70.50 | 5,697,676 | |
29 Aug 24 | Jones James | Common Stock | Acquire L | No | Yes | 1.41 | 50 | 70.50 | 35,526 | |
29 Aug 24 | Krogulski Kenneth | Common Stock | Acquire L | No | Yes | 1.41 | 250 | 352.50 | 251,894 | |
29 Aug 24 | Young Caroline | Common Stock | Acquire L | No | Yes | 1.41 | 25 | 35.25 | 27,845 | |
29 Aug 24 | Young Caroline | Common Stock | Acquire L | No | Yes | 1.41 | 25 | 35.25 | 27,845 |